Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long-term Study of APTA-2217 in Adult Patients With Bronchial Asthma

NCT00246922 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00246922
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00246922 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long-term Study of APTA-2217 in Adult Patients With Bronchial Asthma
Lead sponsor
AstraZeneca
Phase
Phase 3
Overall status
Completed
Start date
December 1, 2004
Completion date
October 1, 2007
Enrollment
150
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bronchial asthma